Pifeltro (doravirine) is an HIV antiretroviral (ARV) medication. It's only for people who've never taken HIV ARVs or who're currently on HIV ARVs and have a viral load of less than 50 copies/mL. Pifeltro (doravirine) is only taken once a day, but needs to be take in combination with other HIV ARVs. Some common side effects include dizziness, nausea, and headaches.
Pifeltro (doravirine) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It stops an important enzyme (reverse transcriptase), which prevents the HIV virus from making copies of itself and spreading.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Please note: Pifeltro (doravirine) was taken with other HIV AVRs during clinical trials, so side effects might not all be caused by Pifeltro (doravirine) alone.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
You can take Pifeltro (doravirine) any time of the day. The most important thing is to pick a time of day when you'll always remember. Many people find it helpful to take their HIV ARVs at the same time. Yet, if you experience a lot of side effects, like dizziness or headache with Pifeltro (doravirine), taking it at night allows you to sleep through them. Talk with your provider if you have questions about when's the best time to take your medication.
There isn't enough information to know if Pifeltro (doravirine) is safe in pregnancy. Let your provider know if you have plans to become pregnant, there might be other HIV regimens that are appropriate and have data regarding pregnancy safety. Your provider can also discuss with you the benefits and risk of taking Pifeltro (doravirine) while pregnant. If you decide to take this medication during pregnancy, you're encouraged to enroll in the Antiretroviral Pregnancy Registry (APR) by calling 1-800-258-4263 to help researchers better understand how Pifeltro (doravirine) affects pregnancy.
There isn't enough information to know if Pifeltro (doravirine) is safe during breastfeeding. Generally speaking, it's not recommended for people with HIV to breastfeed due to the risk of passing HIV to the breastfed infant. Talk with your provider if you have any questions about Pifeltro (doravirine) and breastfeeding.
It's best not to miss a dose of Pifeltro (doravirine). If you miss a dose of Pifeltro (doravirine), the amount of medication in your system might become too low to stop the HIV virus from spreading. If this happens, there's a chance that the new HIV viruses can become resistant and can't be treated with Pifeltro (doravirine), even if the medication levels are the right amount in the future. If you do miss a dose of Pifeltro (doravirine), take it as soon as possible. But if it's almost time for your next dose, just skip the missed dose and take your next dose at the usual time. Don't double up on your medication to make up for missed doses.
The FDA approved Pifeltro (doravirine) for people new to HIV ARVs, and for people who have controlled HIV on their current regimen, but want to change. This comes from the results of the company's DRIVE-SHIFT trial, which studied a HIV ARV regimen switch to a regimen containing Pifeltro (doravirine), in people who had low viral loads. Right now, there isn't any data regarding a HIV ARV switch to Pifeltro (doravirine) in people with high viral loads on their current HIV ARV regimen. Talk with your provider if you're considering starting or switching to Pifeltro (doravirine).
Pifeltro (doravirine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Always make sure your healthcare team has a full list of the medications you're taking, including over-the-counter (OTC) medications and supplements. Don't start taking new medications without talking to your provider or pharmacist. Many medications can interact with Pifeltro (doravirine). Some interactions, such as with carbamazepine (Tegretol), rifampin (Rifadin), and nevirapine (Viramune), lowers Pifeltro (doravirine) levels in your body and cause this medication to not work well.
Pifeltro (doravirine) can cause harmful inflammation in your body as it starts to work. This is because as the medication helps you fight HIV, your immune system starts to recover and becomes more active in fighting other infections. This is good, but can also lead to a lot of inflammation, which can be bad. Your healthcare provider might order labs to check your body for infections before starting your Pifeltro (doravirine), especially if it's your first time taking an HIV ARV. If you do have other infections, you might need to get those treated first before you can start this medication. Call your provider if you experience fever, difficulty breathing, or sudden changes to your health after starting Pifeltro (doravirine).
The inflammation caused by Pifeltro (doravirine) can also lead to autoimmune problems in your body. This can happen months after you start this medication. Let your provider know experience any fever, aches and pains all over your body, extreme tiredness, or rash.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 100mg of | 30 tablets | $1,812.59 | $60.42 |
The typical dose is 100 mg by mouth daily, with or without food.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Pifeltro (doravirine) will not be safe for you to take.